A Case of Bilateral Multifocal Choroiditis Associated with BRAF/MEK Inhibitor Use for Metastatic Cutaneous Melanoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Case of Bilateral Multifocal Choroiditis Associated with BRAF/MEK Inhibitor Use for Metastatic Cutaneous Melanoma
Authors
Keywords
-
Journal
OCULAR IMMUNOLOGY AND INFLAMMATION
Volume -, Issue -, Pages 1-5
Publisher
Informa UK Limited
Online
2021-05-20
DOI
10.1080/09273948.2021.1928714
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravitreal Steroid Treatment for Uveitis Associated with Dabrafenib and Trametinib for Metastatic Cutaneous Melanoma
- (2020) Nora Woltsche et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
- (2019) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy
- (2018) Taku Fujimura et al. JOURNAL OF DERMATOLOGY
- Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
- (2018) Reinhard Dummer et al. LANCET ONCOLOGY
- New features in MEK retinopathy
- (2018) Pallavi Tyagi et al. BMC Ophthalmology
- Choroidal Neovascularization in Multifocal Choroiditis after Dabrafenib and Trametinib
- (2017) Giorgia C. Albertini et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Ocular toxicity due to Trametinib and Dabrafenib
- (2017) Stephanie Sarny et al. BMC Ophthalmology
- Ocular toxicities of MEK inhibitors and other targeted therapies
- (2016) N. Stjepanovic et al. ANNALS OF ONCOLOGY
- MEK inhibitor-associated retinopathy (MEKAR) in metastatic melanoma: Long-term ophthalmic effects
- (2016) U. Urner-Bloch et al. EUROPEAN JOURNAL OF CANCER
- Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report
- (2016) Jennifer Lim et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Bilateral Ischemic Retinal Vasculitis in Metastatic Cutaneous Melanoma Patient Treated with Dabrafenib and Trametinib: A Case Report
- (2016) Alfredo Niro et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Ocular Toxicity in BRAF Mutant Cutaneous Melanoma Patients Treated With Vemurafenib
- (2014) Christina H. Choe et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Transient MEK inhibitor-associated retinopathy in metastatic melanoma
- (2014) U. Urner-Bloch et al. ANNALS OF ONCOLOGY
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of inhibition of the FGFR–MAPK signaling pathway on the development of ocular toxicities
- (2013) Ruud van der Noll et al. CANCER TREATMENT REVIEWS
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search